Table 2.
Percentage of patients with diabetes and control individuals reporting moderate and severe problems in each EQ-5D dimension by disease duration
|
Diabetes duration |
|
|
|||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
1 year |
|
8 years |
|
15 years |
|
24 years |
|
Comparison of individuals with diabetes |
Comparison of control individuals |
||||||||||||
|
(2008 cohort) |
|
(1999 cohort) |
|
(1992 cohort) |
|
(1983 cohort) |
|
||||||||||||||
|
Individuals with diabetes |
Control individuals |
pa |
Individuals with diabetes |
Control individuals |
pa |
Individuals with diabetes |
Control individuals |
pa |
Individuals with diabetes |
Control individuals |
pa |
||||||||||
|
n = 141 |
n = 247 |
|
n = 208 |
n = 381 |
|
n = 225 |
n = 419 |
|
n = 265 |
n = 517 |
|
pb |
pc |
||||||||
% | n | % | n | % | n | % | n | % | n | % | n | % | n | % | n | |||||||
Mobility |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Women |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Moderate problems |
5.7 |
3 |
4.0 |
4 |
0.69 |
6.4 |
6 |
3.6 |
6 |
0.36 |
11.7 |
11 |
9.3 |
16 |
0.54 |
16.1 |
18 |
9.9 |
19 |
0.049 |
0.053 |
0.053 |
Severe problems |
0.0 |
0 |
0.0 |
0 |
|
0.0 |
0 |
0.0 |
0 |
|
0.0 |
0 |
0.0 |
0 |
|
0.9 |
1 |
0.0 |
0 |
|
|
|
Men |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Moderate problems |
2.3 |
2 |
2.7 |
4 |
1.00 |
2.6 |
3 |
5.6 |
12 |
0.22 |
10.7 |
14 |
4.9 |
12 |
0.033 |
17.6 |
27 |
15.9 |
50 |
0.51 |
<0.001 |
<0.001 |
Severe problems |
0.0 |
0 |
0.0 |
0 |
|
0.0 |
0 |
0.0 |
0 |
|
0.0 |
0 |
0.0 |
0 |
|
0.7 |
1 |
0.0 |
0 |
|
|
|
Self-care |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Women |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Moderate problems |
0.0 |
0 |
0.0 |
0 |
- |
0.0 |
0 |
0.6 |
1 |
1.00 |
1.1 |
1 |
2.3 |
4 |
0.43 |
2.7 |
3 |
0.5 |
1 |
0.023 |
0.048 |
0.059 |
Severe problems |
0.0 |
0 |
0.0 |
0 |
|
0.0 |
0 |
0.0 |
0 |
|
0.0 |
0 |
0.6 |
1 |
|
1.8 |
2 |
0.0 |
0 |
|
|
|
Men |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Moderate problems |
1.1 |
1 |
0.0 |
0 |
0.38 |
1.8 |
2 |
0.9 |
2 |
0.61 |
3.8 |
5 |
1.6 |
4 |
0.10 |
3.3 |
5 |
1.9 |
6 |
0.58 |
0.37 |
0.11 |
Severe problems |
0.0 |
0 |
0.0 |
0 |
|
0.0 |
0 |
0.0 |
0 |
|
0.8 |
1 |
0.0 |
0 |
|
0.7 |
1 |
1.0 |
3 |
|
|
|
Usual activities |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Women |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Moderate problems |
13.2 |
7 |
3.0 |
3 |
0.048 |
12.8 |
12 |
7.7 |
13 |
0.18 |
14.9 |
14 |
6.4 |
11 |
0.029 |
20.5 |
23 |
8.4 |
16 |
0.001 |
0.19 |
0.42 |
Severe problems |
0.0 |
0 |
1.0 |
1 |
|
0.0 |
0 |
0.0 |
0 |
|
2.1 |
2 |
1.7 |
3 |
|
2.7 |
3 |
1.5 |
3 |
|
|
|
Men |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Moderate problems |
9.1 |
8 |
3.4 |
5 |
0.033 |
4.4 |
5 |
6.6 |
14 |
0.64 |
9.9 |
13 |
7.7 |
19 |
0.31 |
12.4 |
19 |
8.6 |
27 |
0.14 |
0.090 |
0.065 |
Severe problems |
2.3 |
2 |
0.7 |
1 |
|
1.8 |
2 |
0.9 |
2 |
|
2.1 |
3 |
1.2 |
3 |
|
3.9 |
6 |
2.9 |
9 |
|
|
|
Pain/discomfort |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Women |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Moderate problems |
28.3 |
15 |
25.7 |
26 |
0.35 |
45.7 |
43 |
31.5 |
53 |
0.050 |
48.9 |
46 |
35.5 |
61 |
0.013 |
51.8 |
58 |
47.5 |
96 |
0.33 |
0.041 |
<0.001 |
Severe problems |
5.7 |
3 |
1.0 |
1 |
|
1.1 |
1 |
3.0 |
5 |
|
5.3 |
5 |
2.9 |
5 |
|
4.5 |
5 |
3.0 |
6 |
|
|
|
Men |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Moderate problems |
22.7 |
20 |
24.7 |
36 |
0.77 |
28.9 |
33 |
32.4 |
69 |
0.41 |
24.4 |
32 |
40.1 |
99 |
0.012 |
49.7 |
76 |
44.8 |
141 |
0.12 |
<0.001 |
<0.001 |
Severe problems |
2.3 |
2 |
2.1 |
3 |
|
0.9 |
1 |
1.9 |
4 |
|
6.1 |
8 |
3.6 |
9 |
|
7.2 |
11 |
4.4 |
14 |
|
|
|
Anxiety/depression |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Women |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Moderate problems |
32.0 |
17 |
30.7 |
31 |
0.60 |
36.2 |
34 |
27.4 |
46 |
0.13 |
38.3 |
36 |
29.7 |
51 |
0.057 |
46.4 |
52 |
36.0 |
73 |
0.056 |
0.29 |
0.41 |
Severe problems |
3.8 |
2 |
1.0 |
1 |
|
2.1 |
2 |
1.8 |
3 |
|
8.5 |
8 |
5.2 |
9 |
|
1.8 |
2 |
1.0 |
2 |
|
|
|
Men |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Moderate problems |
28.4 |
25 |
23.3 |
34 |
0.14 |
30.7 |
35 |
24.9 |
53 |
0.13 |
25.2 |
33 |
31.6 |
78 |
0.22 |
31.4 |
48 |
23.2 |
73 |
0.064 |
0.43 |
0.28 |
Severe problems | 6.8 | 6 | 2.7 | 4 | 3.5 | 4 | 1.4 | 3 | 1.5 | 2 | 1.2 | 3 | 3.3 | 5 | 3.2 | 10 |
a P-value for comparison between patients with diabetes and control individuals (χ2 or Fisher exact test), b p-value for comparison between patients with diabetes in the different cohorts (ANOVA), c p-value for comparison between control individuals in the different cohorts (ANOVA).